{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Recent Development Highlighting The Off-Label Paradox",
"url": "https://www.lexblog.com/2014/09/09/recent-development-highlighting-off/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-Z0RRX7XM",
"url": "https://www.lexblog.com/lib/Z0RRX7XM/"
},
"datePublished": "2014-09-09T19:40:00-04:00",
"dateModified": "2022-12-02T11:26:10-05:00",
"author": {
"@type": "Person",
"name": "Bexis"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Drug & Device Law Blogging Team"
},
"organizationScope": "at-publication",
"isPartOf": "Drug & Device Law",
"about": "Health Care and Life Sciences",
"sourceUrl": "http://druganddevicelaw.reedsmithblogs.com/2014/09/09/recent-development-highlighting-off/",
"sourceStability": "may-move"
}